Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up
2007

Hearing Loss in Multi-Drug Resistant Tuberculosis Patients Treated with Aminoglycosides

Sample size: 64 publication Evidence: moderate

Author Information

Author(s): Duggal Prahlad, Sarkar Malay

Primary Institution: Dr. Rajinder Prasad Govt. Medical College, Tanda, Kangra, Himachal Pradesh, India

Hypothesis

The study investigates the impact of second line aminoglycoside anti-tubercular drugs on the hearing status of MDR-TB patients.

Conclusion

Aminoglycosides used in MDR-TB patients may result in irreversible hearing loss involving higher frequencies.

Supporting Evidence

  • 18.75% of patients developed sensorineural hearing loss involving higher frequencies.
  • 6.25% had involvement of speech frequencies.
  • All hearing losses were permanent with no threshold improvement after aminoglycoside discontinuation.

Takeaway

Some medicines for tuberculosis can hurt your hearing, and once that happens, it can't be fixed.

Methodology

The study included 64 patients treated with second line aminoglycosides, with audiometric evaluations performed before, during, and after treatment.

Limitations

The study did not measure serum aminoglycoside levels due to cost constraints.

Participant Demographics

Patients aged 17 to 65 years, with 60.9% male and 39.1% female, mostly from rural backgrounds and low socio-economic status.

Digital Object Identifier (DOI)

10.1186/1472-6815-7-5

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication